A highly specific heterologous enzyme immunoassay for 5α-androstane-3α, 17β-diol 17-glucuronide (androstanediol-17G) and developmental patterns of urinary androstanediol-17G excretions

Steroids

Volumn 67, Issue 3-4, 2002, Pages 175-183

  Onishi, Toshikazu ^a   Takei, Hajime ^b   Kambegawa, Akira ^c   Saisho, Sumitaka ^a   Kashimada, Kenichi ^a   Koyama, Satomi ^a   Mizutani, Shuki ^a   Rao, Pemmaraju N ^d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Tokyo Association of Health Service   (Japan)

^c Kambegawa Laboratory   (Japan)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Androstanediol glucuronide; Developmental pattern; Enzyme immunoassay; Heterologous tracer; Normal range; Urine sample

Indexed keywords

5ALPHA ANDROSTANE 3ALPHA,17BETA DIOL 17 GLUCURONIDE; ANDROSTANEDIOL; GLUCURONIDE; UNCLASSIFIED DRUG;

ACCURACY; ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPMENT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; INTERMETHOD COMPARISON; MALE; RADIOIMMUNOASSAY; SEX DIFFERENCE; STEROL EXCRETION; TECHNIQUE; URINALYSIS;

ADOLESCENT; ADULT; ANDROSTANE-3,17-DIOL; CHILD; CHILD, PRESCHOOL; FEMALE; HORSERADISH PEROXIDASE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; MALE; QUALITY CONTROL; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS;

ARMORACIA RUSTICANA; BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 0036172466     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(01)00152-0     Document Type: Article

References (30)

1. Recent studies on the mechanism of action of testosterone
2. Testosterone metabolism in human bone
3. Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats
4. The source of plasma dihydrotestosterone in man
5. The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-α-androstanediols
6. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome
7. Dihydrotestosterone is a peripheral paracrine hormone
8. Origin of plasma androstanediol glucuronide in men
9. Production of 3 α-androstanediol glucuronide in human genital skin
10. Precursors of plasma androstanediol- and androgen-glucuronides in women
11. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans
12. 3 α, 17 β-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism
13. Contribution of plasma androstenedione to 5 α-androstanediol glucuronide in women with idiopathic hirsutism
14. Measurements of 3 α, 17 β-androstanediol glucuronide in serum and urine and the correlation with skin 5 α-reductase activity
15. Decreased 3 α-androstanediol glucuronide levels in plasma and random urines in male pseudohermaphroditism caused by 5 α-reductase deficiency
16. Serum 3 α-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy
17. 3 α-androstanediol glucuronide in virilizing congenital adrenal hyperplasia; a useful serum metabolic marker of integrated adrenal androgen secretion
18. Androstanediol glucuronide isomers in normal men and women and in men infused with labeled dihydrotestosterone
19. Androgen conjugates; physiology and clinical significance
20. Isolation and identification of androstanediol glucuronide from human plasma
21. Synthesis of new steroid haptens for radioimmunoassay-VIII. Development and validation of a specific radioimmunoassay for serum 5 α-androstane-3 α, 17 β-diol 17-glucuronide
22. A direct radioimmunoassay for 5 α-androstane-3 α,17 β-diol 17-glucuronide
23. The preparation of 5 β-pregnane-3 α,17,20 α-triol 3 α-yl β-D-glucopyranosiduronic acid and its [6,7-3H]-analogue
24. The preparation of steroid N-hydroxysuccinimide esters and their reactivities with BSA
25. Simultaneous determination of urinary androgen glucuronides by high temperature gas chromatography-mass spectrometry with selected ion monitoring
26. Ideal conditions for hydrolysis of androstanediol 3 α, 17 β-diol glucuronide in plasma
27. Urinary excretion of androgen metabolites, comparison with excretion of radioactive metabolites after injection of [4-14C]testosterone. Influence of age
28. Developmental patterns of serum 3 α-androstanediol glucuronide
29. Bloodspot 17 α-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy
30. Home monitoring of 17 hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples